Request Demo
Last update 23 Oct 2025
Mesothelin-TILs(Guangdong Zhaotai InVivo Biomedicine)
Last update 23 Oct 2025
Overview
Basic Info
Drug Type TIL therapy |
Synonyms- |
Target |
Action inhibitors |
Mechanism HPK1 inhibitors(Mitogen-activated protein kinase kinase kinase kinase 1 inhibitors), MSLN inhibitors(Mesothelin inhibitors), PD-1 inhibitors(Programmed cell death protein 1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
1
Clinical Trials associated with Mesothelin-TILs(Guangdong Zhaotai InVivo Biomedicine)NCT04842812
Engineered TILs/CAR-TILs With PD1 Knockout and Anti-PD1/CTLA4-scFv Secreting or CARs Against Various Antigens to Treat Advanced Solid Tumors
100 Clinical Results associated with Mesothelin-TILs(Guangdong Zhaotai InVivo Biomedicine)
Login to view more data
100 Translational Medicine associated with Mesothelin-TILs(Guangdong Zhaotai InVivo Biomedicine)
Login to view more data
100 Patents (Medical) associated with Mesothelin-TILs(Guangdong Zhaotai InVivo Biomedicine)
Login to view more data
100 Deals associated with Mesothelin-TILs(Guangdong Zhaotai InVivo Biomedicine)
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Advanced Malignant Solid Neoplasm | Phase 1 | China | 01 Jan 2021 | |
| Brain Cancer | Phase 1 | China | 01 Jan 2021 | |
| Breast Cancer | Phase 1 | China | 01 Jan 2021 | |
| Colorectal Cancer | Phase 1 | China | 01 Jan 2021 | |
| Liver Cancer | Phase 1 | China | 01 Jan 2021 | |
| Lung Cancer | Phase 1 | China | 01 Jan 2021 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free